ClinicalTrialsFinder

Advanced Urothelial Cancer Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Metastatic Urothelial CarcinomaAdvanced Urothelial Cancer
Generate Biomedicines37 enrolled7 locationsNCT07484022